Multicentric castleman's disease: A challenging diagnosis

Györgyi Műzes, Ferenc Sipos, Judit Csomor, Lídia Sréter

Research output: Contribution to journalReview article

15 Citations (Scopus)


Multicentric Castleman's disease (MCD) is a sytemic disorder with flares of non-specific symptoms suggestive of a chronic inflammatory syndrome. It is typically accompanied by generalized lymphadenopathy and multiorgan involvement. Histologically, two main variants of Castleman's disease exist, the hyalin vascular type and the plasma cell variant. Upon localization unicentric (localized), and multicentric (diffuse, systemic) subtypes can be distinguished with more different disease outcomes. Patients often exhibit acute phase reactions and several autoimmune phenomena, and are at high risk for developing malignancies. Both the idiopathic and the HHV-8-driven infectious forms of MCD represent distinct disease entities with a less favorable prognosis. The induction of human IL-6 excess via yet unknown upstream mechanisms, and overexpression of viral IL-6 by HHV-8 can pivotally influence MCD biology. Based on the role of IL-6 in pathogenesis, MCD is also designated as IL-6 lymphadenopathy. To date there are no direct therapeutic evidences, but having been translated to daily practice the main regulatory factors may serve as promising therapeutic targets.

Original languageEnglish
Pages (from-to)345-351
Number of pages7
JournalPathology and Oncology Research
Issue number3
Publication statusPublished - Jul 2013


  • Differential diagnosis
  • HHV-8
  • IL-6
  • Monoclonal antibodies
  • Multicentric Castleman's disease
  • Therapy

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Multicentric castleman's disease: A challenging diagnosis'. Together they form a unique fingerprint.

  • Cite this